122 related articles for article (PubMed ID: 7516564)
1. Structural implications of somatic mutations during the immune response to 2-phenyloxazolone.
Spinelli S; Alzari PM
Res Immunol; 1994 Jan; 145(1):41-5. PubMed ID: 7516564
[No Abstract] [Full Text] [Related]
2. Three-dimensional structure determination of an anti-2-phenyloxazolone antibody: the role of somatic mutation and heavy/light chain pairing in the maturation of an immune response.
Alzari PM; Spinelli S; Mariuzza RA; Boulot G; Poljak RJ; Jarvis JM; Milstein C
EMBO J; 1990 Dec; 9(12):3807-14. PubMed ID: 2123450
[TBL] [Abstract][Full Text] [Related]
3. Molecular modelling study of antigen binding to oxazolone-specific antibodies: the Ox1 idiotypic IgG and its mature variant with increased affinity to 2-phenyloxazolone.
Holm L; Laaksonen L; Kaartinen M; Teeri TT; Knowles JK
Protein Eng; 1990 Apr; 3(5):403-9. PubMed ID: 2349210
[TBL] [Abstract][Full Text] [Related]
4. Use of 2D NMR, protein engineering, and molecular modeling to study the hapten-binding site of an antibody Fv fragment against 2-phenyloxazolone.
McManus S; Riechmann L
Biochemistry; 1991 Jun; 30(24):5851-7. PubMed ID: 2043627
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutation and the maturation of immune response to 2-phenyl oxazolone.
Griffiths GM; Berek C; Kaartinen M; Milstein C
Nature; 1984 Nov 15-21; 312(5991):271-5. PubMed ID: 6504141
[TBL] [Abstract][Full Text] [Related]
6. V genes of the primary antibody response of C57BL/10 mice to the hapten phenyloxazolone.
Kaartinen M; Pelkonen E; Even J; Mäkelä O
Eur J Immunol; 1988 Jul; 18(7):1095-100. PubMed ID: 3136024
[TBL] [Abstract][Full Text] [Related]
7. Mutation and selection during the secondary response to 2-phenyloxazolone.
Rada C; Gupta SK; Gherardi E; Milstein C
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5508-12. PubMed ID: 1905811
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization and structural modeling of immunoglobulin variable regions from murine monoclonal antibodies specific for hepatitis B virus surface antigen.
Lohman KL; Kieber-Emmons T; Kennedy RC
Mol Immunol; 1993 Oct; 30(14):1295-306. PubMed ID: 7692242
[TBL] [Abstract][Full Text] [Related]
9. Original and artificial antibodies.
Gherardi E; Milstein C
Nature; 1992 May; 357(6375):201-2. PubMed ID: 1589019
[No Abstract] [Full Text] [Related]
10. The importance of the diversity region YYGS motif in anti-DNA antibody binding to DNA.
Mahmoudi M; Bell DA; Cairns E
Ann N Y Acad Sci; 1995 Sep; 764():424-6. PubMed ID: 7486557
[No Abstract] [Full Text] [Related]
11. Light chain germ-line genes and the immune response to 2-phenyloxazolone.
Even J; Griffiths GM; Berek C; Milstein C
EMBO J; 1985 Dec; 4(13A):3439-45. PubMed ID: 3937727
[TBL] [Abstract][Full Text] [Related]
12. Several V genes participate in the early phenyloxazolone response in various combinations.
Kaartinen M; Pelkonen J; Mäkelä O
Eur J Immunol; 1986 Jan; 16(1):98-105. PubMed ID: 3081356
[TBL] [Abstract][Full Text] [Related]
13. Thymus-independent type 2 antigen induces a long-term IgG-related network memory.
Lange H; Zemlin M; Tanasa RI; Trad A; Weiss T; Menning H; Lemke H
Mol Immunol; 2008 May; 45(10):2847-60. PubMed ID: 18329101
[TBL] [Abstract][Full Text] [Related]
14. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
15. Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig.
Neshat MN; Goodglick L; Lim K; Braun J
Int Immunol; 2000 Mar; 12(3):305-12. PubMed ID: 10700465
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of the maternally induced affinity enhancement in the non-Ox1 idiotypic antibody repertoire of the primary immune response to 2-phenyloxazolone.
Lange H; Kobarg J; Yazynin S; Solterbeck M; Henningsen M; Hansen H; Lemke H
Scand J Immunol; 1999 Jan; 49(1):55-66. PubMed ID: 10023858
[TBL] [Abstract][Full Text] [Related]
17. "Diabodies": small bivalent and bispecific antibody fragments.
Holliger P; Prospero T; Winter G
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6444-8. PubMed ID: 8341653
[TBL] [Abstract][Full Text] [Related]
18. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
[TBL] [Abstract][Full Text] [Related]
19. Cloning, sequencing and expression of immunoglobulin variable regions of murine monoclonal antibodies specific for the P1.7 and P1.16 PorA protein loops of Neisseria meningitidis.
Ihle Ø; Beckstrøm KJ; Michaelsen TE
Scand J Immunol; 2003 May; 57(5):453-62. PubMed ID: 12753502
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional model of the BR96 monoclonal antibody variable fragment.
Bajorath J
Bioconjug Chem; 1994; 5(3):213-9. PubMed ID: 7522581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
